Skip to main content
OpenTrials

Clinical trial condition

Chemotherapeutic Agent Toxicity

Explore clinical trials studying Chemotherapeutic Agent Toxicity. Study availability and eligibility vary by location and protocol.

19 public trials 1 recruiting study
Refine in advanced search Browse all conditions

Chemotherapeutic Agent Toxicity trial results

Completed

Glutathione in Preventing Peripheral Neuropathy Caused by Paclitaxel and Carboplatin in Patients With Ovarian Cancer, Fallopian Tube Cancer, and/or Primary Peritoneal Cancer

NCT02311907

Conditions
Adnexal Diseases, Chemically-Induced Disorders, Chemotherapeutic Agent Toxicity, +37 more
Locations
  • Providence Hospital Mobile, Alabama, United States
  • Fairbanks Memorial Hospital Fairbanks, Alaska, United States
  • Mayo Clinic in Arizona Scottsdale, Arizona, United States
  • Northbay Cancer Center Fairfield, California, United States
View all 390 locations
View Trial Details
Completed

Randomized Amifostine For SCCHN

NCT00095927

Conditions
Carcinoma, Carcinoma, Squamous Cell, Chemotherapeutic Agent Toxicity, +18 more
Locations
  • Goodall Hospital Sanford, Maine, United States
  • Massachusetts General Hospital Boston, Massachusetts, United States
  • Dana-Farber Cancer Institute Boston, Massachusetts, United States
  • Beth Israel Deaconess Medical Center Boston, Massachusetts, United States
View Trial Details
Completed

Acute Pain Caused by Paclitaxel in Patients With Cancer

NCT00860041

Conditions
Chemically-Induced Disorders, Chemotherapeutic Agent Toxicity, Nervous System Diseases, +8 more
Locations
  • Aurora Presbyterian Hospital Aurora, Colorado, United States
  • Boulder Community Hospital Boulder, Colorado, United States
  • Penrose Cancer Center at Penrose Hospital Colorado Springs, Colorado, United States
  • St. Anthony Central Hospital Denver, Colorado, United States
View all 279 locations
View Trial Details
Completed

Cisplatin and Paclitaxel in Treating Patients With Stage IIB, Stage IIC, Stage III, or Stage IV Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cavity Cancer

NCT00814086

Conditions
Adnexal Diseases, Brenner Tumor, Chemically-Induced Disorders, +40 more
Locations
  • University of Chicago Comprehensive Cancer Center Chicago, Illinois, United States
  • University of Iowa Hospitals and Clinics Iowa City, Iowa, United States
  • Cooper Hospital University Medical Center Camden, New Jersey, United States
  • Riverside Methodist Hospital Columbus, Ohio, United States
View Trial Details

Related conditions